Genetic divergence of hepatitis C virus: The role of HIV-related immunosuppression

Journal of Acquired Immune Deficiency Syndromes

Volumn 49, Issue 2, 2008, Pages 136-141

  Netski, Dale M ^a   Mao, Qing ^a   Ray, Stuart C ^a,c   Klein, Robert S ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E1; GLYCOPROTEIN E2; VIRUS ENVELOPE PROTEIN; E1 PROTEIN, HEPATITIS C VIRUS; GLYCOPROTEIN E2, HEPATITIS C VIRUS;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENETIC VARIABILITY; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS ENVELOPE; VIRUS GENOME; CLASSIFICATION; DNA SEQUENCE; GENETIC POLYMORPHISM; GENETICS; HEPATITIS C; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; MIDDLE AGED; MISSENSE MUTATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; VIROLOGY;

ADULT; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; IMMUNE TOLERANCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MUTATION, MISSENSE; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; VIRAL ENVELOPE PROTEINS;

EID: 55249106625     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181869a6f     Document Type: Article

References (35)

1. World Health Organization. Hepatitis C: global prevalence. Wkly Epidemiol Rec. 1997;72:341-348.
2. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341:556-562.
3. Sherman KE, Rouster SD, Chung RT, et al. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a crosssectional analysis of the US Adult AIDS Clinical Trials Group. Clin Infect Dis. 2002;34:831-837.
4. Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a metaanalysis. Clin Inject Dis. 2001;33:562-569.
5. Choo QL, Richman KH, Han JH, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA. 1991;88:2451-2455.
6. Martell M, Esteban JI, Quer J, et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol. 1992;66:3225-3229.
7. Kato N, Ootsuyama Y, Tanaka T, et al. Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Res. 1992;22: 107-123.
8. Neumann AU, Lam NP, Dahari H, et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science. 1998;282: 103-107.
9. Tuplin A, Wood J, Evans DJ, et al. Thermodynamic and phylogenetic prediction of RNA secondary structures in the coding region of hepatitis C virus. RNA. 2002;8:824-841.
10. Evans DT, O'Connor DH, Jing P, et al. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nat Med. 1999;5:1270-1276.
11. Ray SC, Mao Q, Lanford RE, et al. Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees. J Virol. 2000; 74:3058-3066.
12. Sherman KE, O'Brien J, Gutierrez AG, et al. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections. J Clin Microbiol. 1993;31:2679-2682.
13. Thomas DL, Shih JW, Alter HJ, et al. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis. 1996;174:690-695.
14. Fishbein DA, Lo Y, Netski D, et al. Predictors of hepatitis C virus RNA levels in a prospective cohort study of drug users. J Acquir Immune Defic Syndr. 2006;41:471-476.
15. Thomas DL, Astemborski J, Vlahov D, et al. Determinants of the quantity of hepatitis C virus RNA. J Infect Dis. 2000;181:844-851.
16. Strasfeld L, Lo Y, Netski D, et al. The association of hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users. J Acquir Immune Defic Syndr. 2003;33:356-3564.
17. Mao Q, Ray SC, Laeyendecker O, et al. Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies. J Virol. 2001;75:3259-3267.
18. Ray SC, Wang YM, Laeyendecker O, et al. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as decoy. J Virol. 1998;73:2938-2946.
19. Cabot B, Esteban JI, Martell M, et al. Structure of replicating hepatitis C virus (HCV) quasispecies in the liver may not be reflected by analysis of circulating HCV virions. J Virol. 1997;71:1732-1734.
20. Hall TA. BioEdit: Biological Sequence Alignment Editor for Windows 95/ 98/NT version 7.0.4. software 2001. Available at: http://www.mbio.ncsu. edu/RNaseP/info/programs/BIOEDIT/bioedit.html. Accessed February 20, 2005.
21. Pond SL, Frost SD, Muse SV HyPhy: hypothesis testing using phylogenies. Bioinformatics. 2005;21:676-679.
22. Muse SV, Gaut BS. A likelihood approach for comparing synonymous and nonsynonymous nucleotide substitution rates, with application to the chloroplast genome. Mol Biol Evol. 1994; 11:715-724.
23. Nei M, Gojobori T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol. 1986;3:418-426.
24. Jukes TH, Cantor TR. Evolution of protein molecules. In: Munro HN, ed. Mammalian Pivtein Metabolism. New York: Academic Press; 1969:21-132.
25. Smith DB, Simmonds P. Characteristics of nucleotide substitution in the hepatitis C virus genome: constraints on sequence change in coding regions at both ends of the genome. J Mol Evol. 1997;45:238-246.
26. Ina Y, Mizokami M, Ohba K, et al. Reduction of synonymous substitutions in the core protein gene of hepatitis C virus. J Mol Evol. 1994;38:50-56.
27. Keenan ED, Rouster SD, Shire NJ, et al. Complexity and diversity of hepatitis C virus RNA in African Americans and whites: analysis of the envelope-coding domain. J Infect Dis. 2004;190:511-514.
28. Toyoda H, Fukuda Y, Koyama Y, et al. Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus. J Hepatol. 1997;26:975-982.
29. Sherman KE, Andreatta C, O'Brien J, et al. Hepatitis C in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain. Hepatology. 1996;23: 688-694.
30. Tanaka Y, Hanada K, Hanabusa H, et al. Increasing genetic diversity of hepatitis C virus in haemophiliacs with human immunodeficiency virus coinfection. J Gen Virol. 2007;88:2513-2519.
31. Roque-Afonso AM, Robain M, Simoneau D, et al. Influence of CD4 cell counts on the genetic heterogeneity of hepatitis C virus in patients coinfected with human immunodeficiency virus. J Infect Dis. 2002;185: 728-733.
32. Shuhart MC, Sullivan DG, Bekele K, et al. HIV infection and antiretroviral therapy: effect on hepatitis C virus quasispecies variability. J Infect Dis. 2006;193:1211-1218.
33. Blackard JT. Yang Y, Bordoni P, et al. Hepatitis C virus (HCV) diversity in HIV-HCV-coinfected subjects initiating highly active antiretroviral therapy. J Infect Dis. 2004;189:1472-1481.
34. Babik JM, Holodniy M. Impact of highly active antiretroviral therapy and immunologic status on hepatitis C virus quasispecies diversity in human immunodeficiency virus/hepatitis C virus-coinfected patients. J Virol. 2003;77:1940-1950.
35. McAllister J, Casino C, Davidson F, et al. Long-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort. J Virol. 1998;72:4893-4905.